Category Archives: Astrazeneca

FDA Approves Two-In-One Diabetes Treatment

The U.S. Food and Drug Administration has approved a new drug from AstraZeneca that combines two drugs in one to help lower blood glucose in those with  . The new drug, Xigduo XR, is a once-daily tablet that merges the recently approved diabetes drug dapagliflozin with the popular drug metformin. Dapagliflozin, a product of AstraZeneca … Continue reading FDA Approves Two-In-One Diabetes Treatment

Once-Weekly Tanzeum for Type 2s Now Available

Tanzeum (albiglutide), a once-weekly injectable drug for type 2s from GSK (GlaxoSmithKline), USA is now available at pharmacies throughout the United States. The FDA approved U.S. sales on April 15. The drug is a glucagon-like peptide-1 receptor agonist (GLP-1) that can be used in conjunction with other type 2 drugs. GLP-1s work by inducing the … Continue reading Once-Weekly Tanzeum for Type 2s Now Available

FDA Delays Final OK for Type 2 Drug Empagliflozin

The FDA will delay allowing the type 2 drug empagliflozin to enter the U.S. market until “previously observed deficiencies” at the plant where it is manufactured are fixed. The delay does not call into question the safety or utility of the drug, which is manufactured by Eli Lilly and Boehringer Ingelheim. Empagliflozin is an SGLT-2 … Continue reading FDA Delays Final OK for Type 2 Drug Empagliflozin

FDA OKs Dapagliflozin as Type 2 Drug

The Food and Drug Administration has approved the entry of dapagliflozin, a drug for treating type 2 diabetes, into the U.S. market. Dapagliflozin, manufactured by Bristol-Myers Squibb and AstraZeneca, will be sold under the brand name Farxiga. The drug belongs to a new class of type 2 medications called SGLT-2 (sodium glucose co-transporter 2) inhibitors … Continue reading FDA OKs Dapagliflozin as Type 2 Drug

Dapagliflozin Teams Well With Metformin, Sulfonylurea

According to researchers, dapagliflozin, a diabetes drug developed jointly by two pharmaceutical companies has shown significant benefits when teamed with metformin and sulfonylurea. The drug, already available in Europe, is produced by Bristol-Myers and AstraZeneca. It has been shown to improve blood sugar levels, help reduce body weight, and lead to lower A1c levels when … Continue reading Dapagliflozin Teams Well With Metformin, Sulfonylurea